MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma

Fondazione IRCCS Policlinico San Matteo, Pavia

MD Anderson Cancer Centre, Madrid

Hospital Universitario Ramon Y Cajal, Madrid

Hospital Universitario 12 de Octubre, Madrid

Groupe Hospitalier Saint Andre - Hopital Saint Andre, Bordeaux

Florida Cancer Specialists, West Palm Beach

Florida Cancer Specialists-Broadway, Venice

IOV - Istituto Oncologico Veneto IRCCS, Padua

Tennessee Oncology, Nashville

Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi, Bologna

Hospital Universitario Virgen del Rocio, Seville

The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital, Columbus

Institut de Cancerologie de l'Ouest Paul Papin, Angers

ICL-Alexis Vautrin, Departement dOncologie Medicale, Vandœuvre-lès-Nancy

Clinique Victor Hugo - Centre Jean Bernard, Le Mans

Groupe Hospitalier Pitie-Salpetriere, Paris

The Center for Cancer and Blood Disorders, Weatherford

Istituto Nazionale Tumori Fondazione G. Pascale, Napoli

USC Norris Comprehensive Cancer Center, Los Angeles

Hackensack University Medical Center PARTNER, Hackensack

CancerCare Manitoba, Winnipeg

McMaster University, Hamilton

Fakultni nemocnice u sv. Anny v Brne, Brno

Fakultni nemocnice Olomouc, Olomouc

Fakultni nemocnice v Motole, Prague

Beskidzkie Centrum Onkologii im.Jana Pawla II, Bielsko-Biala

Instytut MSF, Ulica Pilota Stanislawa Wigury 19, Lodz

Hospital Duran i Reynals, L'Hospitalet de Llobregat

Hospital Universitari Vall d'Hebron, Barcelona

Hospital Clinic i Provincial de Barcelona, Barcelona

Royal Devon and Exeter Hospital (Wonford), Exeter

Lancashire Teaching Hospitals NHS Foundation Trust, Blackburn

Barts Hospital, London

The Christie, Manchester

Velindre Cancer Centre, Cardiff

Royal Surrey County Hospital, Guildford